GPR132 and neoplasm: Consistent with previous results, the mice that received GPR132−/− bone marrow cells exhibited a higher proportion of NK cells in peripheral blood and inside the tumor as well as showed stronger resistance to melanoma compared to the WT group (Fig. 2J and fig.